Givaudan reported 3.65B in Equity Capital and Reserves for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Akzo Nobel AKZA:NA € 5509M 199M
Arkema AKE:FP € 6057M 320M
BASF BAS:GR € 39392M 2109M
Bayer BAYN:GR € 31103M 714M
British American Tobacco BATS:LN 62.9B 224M
Covestro 1COV:GR 7.21B 584M
Croda International CRDA:LN 1.65B 67.2M
Diageo DGE:LN 6.9B 79M
DSM DSM:NA € 7399M 76M
Fresenius FRE:GR € 18301M 602M
Fresenius Medical Care FME:GR € 13446M 1814.05M
Givaudan GIVN:VX 3.65B 162M
Glanbia GLB:ID 1.67B 62.6M
International Flavors Fragrances IFF:US $ 21426M 335M
Johnson Matthey JMAT:LN 2.67B 12M
Kerry Group KYG:ID 4.96B 307.6M
Lonza Group LONN:SW 7.27B 452M
Merck MRK:GR € 20607M 1314M
Solvay SOLB:BB € 8358M 441M
Tate & Lyle TATE:LN 1.51B 48M
Umicore UMI:BB 2.88B 324.72M